Torren Management
NVO icon

Torren Management’s Novo Nordisk NVO Stock Holding History

Torren Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.07K Buy
+160
New +$7.38K ﹤0.01% 297

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Torren Management's NVO Position: Q3 2026 in Review

Torren Management opened a new position in Novo Nordisk (NVO) in Q3 2026: 160 shares worth $6.07K. The stake represents ﹤0.01% of the portfolio and ranks #297 among its holdings.

778 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Torren Management held 160 shares of Novo Nordisk worth $6.07K as of Q3 2026.
  • Novo Nordisk was a new Torren Management position in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Torren Management's portfolio in Q3 2026, its #297 holding.
  • 778 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.